FDA Inspection 868819 — Oklahoma Blood Institute East Central

Oklahoma Blood Institute East Central — FEI 1641495

The FDA completed an inspection of Oklahoma Blood Institute East Central on March 6, 2014 in Ada, OK. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 6, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ada, OK (United States)

Citations

IDCFRDescription
1503021 CFR 606.60(b)Equipment calibration frequency